XML 21 R8.htm IDEA: XBRL DOCUMENT v3.10.0.1
Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)
$ in Thousands
 9 Months Ended
Sep. 26, 2018
Sep. 27, 2017
Cash flows from operating activities:    
Net income $ 32,190 $ 26,447
Adjustments to reconcile net income to cash flows provided by operating activities:    
Depreciation and amortization 19,965 17,493
Operating (gains), losses and other charges, net 1,615 3,459
Amortization of deferred financing costs 455 446
(Gain) loss on early extinguishments of debt and leases (159) 68
Deferred income tax expense 5,044 9,936
Share-based compensation 3,661 6,546
Decrease (increase) in assets:    
Receivables 3,582 3,279
Inventories 83 (55)
Other current assets 1,292 834
Other assets (565) (5,068)
Increase (decrease) in liabilities:    
Accounts payable (11,948) (5,121)
Accrued salaries and vacations (858) (9,094)
Accrued taxes 1,974 1,474
Other accrued liabilities (7,733) (4,834)
Other noncurrent liabilities (2,339) (2,285)
Net cash flows provided by operating activities 46,259 43,525
Cash flows from investing activities:    
Capital expenditures (17,294) (13,558)
Acquisition of restaurants and real estate (10,416) (10,043)
Proceeds from disposition of property 969 2,318
Investment purchases (1,709) 0
Collections on notes receivable 2,478 3,773
Issuance of notes receivable (2,525) (2,278)
Net cash flows used in investing activities (28,497) (19,788)
Cash flows from financing activities:    
Revolver borrowings 91,000 105,900
Revolver payments (72,000) (62,600)
Long-term debt payments (2,429) (2,467)
Proceeds from exercise of stock options 1,058 173
Tax withholding on share-based payments (1,714) 0
Purchase of treasury stock (37,108) (65,951)
Net bank overdrafts 319 279
Net cash flows used in financing activities (20,874) (24,666)
Decrease in cash and cash equivalents (3,112) (929)
Cash and cash equivalents at beginning of period 4,983 2,592
Cash and cash equivalents at end of period $ 1,871 $ 1,663